| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |